Search the Archive

A Closer Look (Cancer) Part III #196914

ABC Evening News for Thursday, May 10, 2001
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Peter Jennings) A list of cancer drugs in development outlined on screen.

(Rockville, MD: Ned Potter) The realities of medical research on cancer drugs like angiogenesis inhibitors, which attack the blood vessels nourishing tumors, examined. [EntreMed, Incorporated chairman Dr. John HOLADAY - expresses optimism about the company's cancer drugs.] [EntreMed, Incorporated Dr. Joanna HOROBIN - comments on the research.] [Prostate cancer patient William STONEMAN - talks about drug trials.] [University of Wisconsin Dr. George WILDING - comments on the slow process for developing a drug.]

Jennings, Peter;
Potter, Ned

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.